AI Accelerates Innovation Across Vaccine Development, Drug Discovery, and Clinical Trials

Key Intelligence

• ■SK bioscience and the Gates Foundation are collaborating to launch an AI-driven platform aimed at accelerating vaccine development.
• ■UN reports highlight artificial intelligence as a significant catalyst for medical breakthroughs.
• ■Major pharmaceutical companies, like Takeda, are partnering to leverage AI for strategic drug discovery initiatives.
• ■AI is being utilized to enhance the efficiency of clinical trials, specifically for patient identification.
• ■The FDA has granted clearance to large language models in healthcare, prompting discussions on their role as interface or decision-maker in medical applications.